TORONTO, Monday, August 14, 2023 – Today, CanPath (the Canadian Partnership for Tomorrow’s Health) has contributed to the first peer-reviewed publication showcasing pan-Canadian seroprevalence estimates – published in the Canadian Medical Association Journal (CMAJ). Seroprevalence refers to how many people across Canada developed antibodies in response to infection or vaccination. Studies like this give us an idea

Data from more than 158,000 Canadians, including almost 80,000 OHS participants, were used to examine why so few Canadians follow recommended screening guidelines for colorectal cancer, even though regular screening is shown to reduce incidents of the disease or death. Based on self-reported data from online questionnaires, it turns out only 47.7 percent of the

A study used data from almost 80,000 Canadians, including almost 6,000 OHS participants, to research the link between sun exposure and the risk of developing Non-Hodgkin Lymphoma (NHL). The research found that moderate daily exposure (30 minutes to two hours) was associated with a lower risk of developing this category of cancer. The authors noted